Speech Sequencing Therapies for Stuttering
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to better understand how the brain plans and produces speech, focusing on individuals who stutter or have speech disorders like primary progressive aphasia. Researchers will use brain imaging and non-invasive techniques, such as Transcranial Direct Current Stimulation (tDCS), to compare speech effects in these groups with those having typical speech patterns. Participants will learn new word sounds and sequences to test how the brain processes speech. The trial seeks native English speakers with either persistent stuttering, typical speech, or primary progressive aphasia. As an unphased study, this trial offers a unique opportunity to contribute to groundbreaking research in speech disorders.
Do I need to stop my current medications to join the trial?
If you have primary progressive aphasia (PPA), you cannot participate if you are taking medications that affect speech or language. For others, the protocol does not specify if you need to stop taking your current medications.
What prior data suggests that these speech sequencing therapies are safe?
Research has shown that transcranial direct current stimulation (tDCS) is generally safe. Studies indicate that people tolerate tDCS well, with only minor side effects such as slight skin irritation or mild tingling at the electrode sites. Serious side effects are rare.
For learning new speech sounds and unfamiliar words, the emphasis is on practice and learning. No evidence suggests major safety concerns with these activities. Practicing new speech patterns is considered safe. Overall, researchers have used the treatments in this study in other research, demonstrating good safety records.12345Why are researchers excited about this trial?
Researchers are excited about the Speech Sequencing Therapies for Stuttering trial because it explores innovative ways to improve speech fluency using combinations of novel sounds and advanced brain stimulation techniques. Unlike traditional speech therapy, which typically involves practicing speech patterns, this trial delves into learning non-native phoneme combinations and novel multisyllabic nonwords. It also uses transcranial direct current stimulation (tDCS) to potentially enhance learning by targeting specific brain areas involved in speech. Additionally, by employing functional magnetic resonance imaging (fMRI), the trial aims to understand the brain activity associated with these new learning methods. This approach could pave the way for more effective and tailored treatments for stuttering and related speech disorders.
What evidence suggests that this trial's treatments could be effective for stuttering?
Research shows that transcranial direct current stimulation (tDCS) combined with specific speech exercises can help adults who stutter speak more fluently. In this trial, some participants will receive anodal tDCS, while others will receive sham tDCS as a control. Studies have found that tDCS can noticeably reduce the frequency and severity of stuttering.
Research has shown that people can learn new sounds in a language with practice, even if they are initially difficult to distinguish. This trial includes arms where participants will engage in learning non-native phoneme combinations, which may improve speech organization in people who stutter.
For learning new, made-up words with many syllables, studies have found that people who stutter might struggle to repeat these words accurately. This trial will test multisyllabic learning in both children and adults, suggesting that focused practice might improve their ability to manage these speech patterns.16789Who Is on the Research Team?
Frank H Guenther, PhD
Principal Investigator
Boston University
Soo-Eun Chang, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for native American English speakers with limited second language exposure. It includes children who pass a hearing test, adults without neurological issues (except stuttering), and those diagnosed with primary progressive aphasia by MGH-FTD. Excluded are individuals with contraindications to MRI or tDCS, certain medication use in PPA patients, severe cognitive impairment, and outside the age range for child participants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo training sessions to learn novel speech sequences using various methods such as tDCS and fMRI
Intervention
Functional MRI and other assessments are conducted to measure brain activity and speech performance
Follow-up
Participants are monitored for changes in speech performance and brain activity post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Anodal tDCS
- Learning of non-native phoneme combinations: 1 training session
- Learning of non-native phoneme combinations: 6 training sessions
- Learning of non-native phoneme combinations: 8 training sessions
- Learning of novel multisyllabic nonwords
- Sham tDCS
Trial Overview
The study investigates brain mechanisms in speech motor planning through experiments involving speech production tasks, functional MRI scans, and non-invasive brain stimulation like sham and anodal tDCS. Participants will learn new phoneme combinations or multisyllabic nonwords across multiple sessions to help understand these processes in people with stuttering or neurodegenerative speech disorders.
How Is the Trial Designed?
7
Treatment groups
Experimental Treatment
Placebo Group
30 adults with primary progressive aphasia (PPA) will participate in this arm. Subjects will learn novel 1-syllable nonsense words formed by non-native phoneme combinations during 8 training sessions over 2 days. Following training, subjects will complete a behavioral test to compare their performance on the words learned during training with a set of unfamiliar words also formed by non-native phoneme combinations.
60 adults with neurotypical speech development will participate in this arm. Subjects will learn novel 1-syllable nonsense words formed by non-native phoneme combinations during 6 training sessions over 2 days. Following training, subjects will participate in a functional magnetic resonance imaging (fMRI) session on a third day to measure brain activity associated with producing the words learned during training and with a set of unfamiliar words also formed by non-native phoneme combinations.
35 adults with neurotypical speech development will participate in this arm. Subjects will learn novel 1-syllable nonsense words formed by non-native phoneme combinations. During the training, anodal transcranial direct current stimulation (tDCS) will be applied to the the subject's left inferior frontal sulcus.
35 adults with neurotypical speech development will participate in this arm. Subjects will learn novel 1-syllable words formed by non-native phoneme combinations. During the training, continuous anodal transcranial direct current stimulation (tDCS) will be applied to the the subject's right cerebellum.
45 children with persistent developmental stuttering (CWS) and 45 children with neurotypical speech development (CNS) will participate in this arm. Subjects will learn nonsense words formed by novel combinations of 2 syllables that are legal in American English during 6 training sessions over 2 days. Behavioral measures extracted from the data will be used to compare performance before and after training and across the CWS and CNS participants.
30 adults persistent developmental stuttering (AWS) and 30 adults with neurotypical speech development (ANS) will participate in this arm. Subjects will learn nonsense words formed by novel combinations of 3 syllables that are legal in American English during 6 training sessions over 2 days. Following training, subjects will participate in a functional magnetic resonance imaging (fMRI) session on a third day to measure brain activity associated with producing the words formed by pairing 2 learned 3-syllable strings learned during training and those formed by pairing 2 unfamiliar 3-syllable strings. Behavioral measures extracted from the data will be used to compare performance before and after training and across the AWS and ANS participants.
35 adults with neurotypical speech development will participate in this arm. Subjects will learn novel 1-syllable words formed by non-native phoneme combinations. During training, Sham transcranial direct current stimulation stimulation (tDCS) will be delivered to the subject's brain.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor
University of Michigan
Collaborator
Massachusetts General Hospital
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Published Research Related to This Trial
Citations
The Effects of tDCS on Speech Fluency in People Who ...
The studies reviewed in this study have reported a variable effectiveness of tDCS for enhancing speech fluency in PWS. As a result, it remains ...
The application of non-invasive neuromodulation in stuttering
The results revealed similar outcomes in terms of speech fluency between anodal and sham conditions. However, they reported that anodal stimulation modulated ...
Transcranial direct current stimulation over left inferior frontal ...
We conclude that transcranial direct current stimulation combined with behavioural fluency intervention can improve fluency in adults who stutter.
Investigating the feasibility of using transcranial direct current ...
We found a significant reduction in stuttering during sentence reading following the choral speech practice, in both the TDCS and sham sessions. The stuttering ...
Efficacy of Noninvasive Brain Stimulation Techniques in ...
Meta-regression showed that transcranial direct current stimulation (tDCS) had the most significant effect in reducing stuttering severity and frequency among ...
Safety of transcranial Direct Current Stimulation: Evidence ...
This review updates and consolidates evidence on the safety of transcranial Direct Current Stimulation (tDCS). Safety is here operationally defined by, ...
Effects of Anodal tDCS on Motor Sequence Practice in ...
The findings of this study will contribute to understanding the feasibility of using anodal tDCS to observe nonspeech motor skill control in people who stutter.
Investigating Speech Sequencing in Neurotypical ...
During the training, anodal transcranial direct current stimulation (tDCS) will be applied to the the subject's left inferior frontal sulcus. Intervention ...
9.
researchgate.net
researchgate.net/publication/316180045_Safety_parameter_considerations_of_anodal_transcranial_Direct_Current_Stimulation_in_ratsSafety parameter considerations of anodal transcranial ...
A commonly referenced transcranial Direct Current Stimulation (tDCS) safety threshold derives from tDCS lesion studies in the rat and relies on ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.